ArcelorMittal SA (MT)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 53.92 |
|---|---|
| 52-week range | 31.87 – 68.56 |
| Return, 1 month / 3 months | −15.5% / −7.2% |
| Return, 1 year / 3 years | +63.2% / +177.1% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 41.5% |
| Worst drawdown (1 year) | -26.2% |
| Average daily value traded | 91.35M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ArcelorMittal makes steel. The company produces flat and long steel products for customers in industries such as automotive, construction, appliances and packaging, and it also mines iron ore and coal to supply its mills. Its operations span many countries across Europe, the Americas, Asia and Africa, and its head office is in Luxembourg. ArcelorMittal serves manufacturers, builders and industrial buyers around the world with steel used in vehicles, buildings, machinery and household goods.
On this site ArcelorMittal SA appears as a stock on the Euronext Amsterdam (Netherlands), code MT, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ArcelorMittal SA (MT) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 53.92 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 48 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 63.2% and over the last three months it fell 7.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.8% | ||
| From 52-week high | -20.2% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.2% | ||
| 6-month return | 3.6% | ||
| 12-month return, skipping the last month | 93.1% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.2% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 91.35M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | −15.5% |
| 3 months | −7.2% |
| 6 months | +3.6% |
| 1 year | +63.2% |
| 3 years | +177.1% |
| 5 years | +113.6% |
Signals
| 50-day / 200-day average | 61.29 / 54.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Nov 2026 | EUR 0.1500 |
| 6 Aug 2026 | EUR 0.1300 |
| 12 May 2026 | EUR 0.1278 |
| 12 Feb 2026 | EUR 0.1262 |
| 12 Nov 2025 | EUR 0.2377 |
| 15 May 2025 | EUR 0.2458 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.